Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Dicerna Pharmaceuticals Inc (DRNA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/29/2021 |
4
| Koppel Adam (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Unknown transaction of 3,080,237 shares
@ $38.25, valued at
$117.8M
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $3.47, valued at
$86.8k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Zeng Ling (Chief Legal Officer & Sec'y) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 5,032 shares
@ $38.25, valued at
$192.5k
Disposed/sold 7,688 restricted stock units
@ $0
Disposed/sold 13,669 restricted stock units
@ $0
Disposed/sold 81,825 options to buy
@ $18.69, valued at
$1.5M
Disposed/sold 46,120 options to buy
@ $24.05, valued at
$1.1M
|
|
| 12/29/2021 |
4
| Weissman James B (COO & EVP) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 18,100 shares
@ $38.25, valued at
$692.3k
Disposed/sold 25,950 restricted stock units
@ $0
Disposed/sold 11,325 restricted stock units
@ $0
Disposed/sold 11,879 options to buy
@ $2.97, valued at
$35.3k
Disposed/sold 33,999 options to buy
@ $9.09, valued at
$309.1k
Disposed/sold 105,000 options to buy
@ $9.3, valued at
$976.5k
Disposed/sold 180,000 options to buy
@ $11.77, valued at
$2.1M
Disposed/sold 111,800 options to buy
@ $16.3, valued at
$1.8M
Disposed/sold 75,000 options to buy
@ $18.5, valued at
$1.4M
Disposed/sold 121,300 options to buy
@ $22.58, valued at
$2.7M
Disposed/sold 68,100 options to buy
@ $24.05, valued at
$1.6M
|
|
| 12/29/2021 |
4
| Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $14.76, valued at
$369k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Pagan Douglas W. (CFO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 7,775 shares
@ $38.25, valued at
$297.4k
Disposed/sold 20,475 restricted stock units
@ $0
Disposed/sold 6,150 restricted stock units
@ $0
Disposed/sold 95,650 options to buy
@ $20.79, valued at
$2M
Disposed/sold 36,900 options to buy
@ $24.05, valued at
$887.4k
|
|
| 12/29/2021 |
4
| KOZIN MARC D (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Disposed/sold 6,333 shares
@ $38.25, valued at
$242.2k
Disposed/sold 5,000 shares
@ $38.25, valued at
$191.3k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $10.31, valued at
$257.8k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| HOFFMAN STEPHEN J (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 16,157 shares
@ $38.25, valued at
$618k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 15,000 options to buy
@ $3.26, valued at
$48.9k
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 15,000 options to buy
@ $13.87, valued at
$208.1k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 25,000 options to buy
@ $16.3, valued at
$407.5k
Disposed/sold 15,000 options to buy
@ $18.73, valued at
$281k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| GRAY PATRICK M. (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $14.32, valued at
$358k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Freed Martin I (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $3.26, valued at
$81.5k
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| FAMBROUGH DOUGLAS (CEO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Disposed/sold 231,431 shares
@ $38.25, valued at
$8.9M
Disposed/sold 59,850 restricted stock units
@ $0
Disposed/sold 41,250 restricted stock units
@ $0
Disposed/sold 191,330 options to buy
@ $2.97, valued at
$568.3k
Disposed/sold 281,250 options to buy
@ $3.42, valued at
$961.9k
Disposed/sold 55,055 options to buy
@ $3.42, valued at
$188.3k
Disposed/sold 225,000 options to buy
@ $9.09, valued at
$2M
Disposed/sold 255,000 options to buy
@ $9.3, valued at
$2.4M
Disposed/sold 505,000 options to buy
@ $11.77, valued at
$5.9M
Disposed/sold 71,900 options to buy
@ $16.3, valued at
$1.2M
Disposed/sold 200,000 options to buy
@ $16.3, valued at
$3.3M
|
|
| 12/29/2021 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $15.61, valued at
$390.3k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Ciappenelli Robert D. (Chief Strategy Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 14,813 shares
@ $38.25, valued at
$566.6k
Disposed/sold 10,275 restricted stock units
@ $0
Disposed/sold 17,325 restricted stock units
@ $0
Disposed/sold 270,000 options to buy
@ $15.61, valued at
$4.2M
Disposed/sold 76,144 options to buy
@ $22.58, valued at
$1.7M
Disposed/sold 61,500 options to buy
@ $24.05, valued at
$1.5M
|
|
| 12/29/2021 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 4,666 shares
@ $38.25, valued at
$178.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 8,000 options to buy
@ $14.13, valued at
$113k
Disposed/sold 25,000 options to buy
@ $14.76, valued at
$369k
Disposed/sold 33,000 options to buy
@ $15.44, valued at
$509.5k
Disposed/sold 21,000 options to buy
@ $21.61, valued at
$453.8k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 12/29/2021 |
4
| Brown Bob D (Chief Scientific Ofr., EVP R&D) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 2,367 shares
@ $38.25, valued at
$90.5k
Disposed/sold 25,950 restricted stock units
@ $0
Disposed/sold 11,325 restricted stock units
@ $0
Disposed/sold 85,000 options to buy
@ $9.09, valued at
$772.7k
Disposed/sold 105,000 options to buy
@ $9.3, valued at
$976.5k
Disposed/sold 180,000 options to buy
@ $11.77, valued at
$2.1M
Disposed/sold 165,050 options to buy
@ $16.3, valued at
$2.7M
Disposed/sold 75,000 options to buy
@ $18.5, valued at
$1.4M
Disposed/sold 121,300 options to buy
@ $22.58, valued at
$2.7M
Disposed/sold 68,100 options to buy
@ $24.05, valued at
$1.6M
|
|
| 12/29/2021 |
4
| Aradhye Shreeram (EVP & Chief Medical Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 6,973 shares
@ $38.25, valued at
$266.7k
Disposed/sold 21,075 restricted stock units
@ $0
Disposed/sold 8,513 restricted stock units
@ $0
Disposed/sold 124,700 options to buy
@ $18.69, valued at
$2.3M
Disposed/sold 51,070 options to buy
@ $24.05, valued at
$1.2M
|
|
| 12/17/2021 |
4
| Pagan Douglas W. (CFO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 602 shares
@ $38.05, valued at
$22.9k
Exercised 2,050 restricted stock units
@ $0 |
|
| 12/17/2021 |
4
| Ciappenelli Robert D. (Chief Strategy Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 1,241 shares
@ $38.05, valued at
$47.2k
Exercised 3,425 restricted stock units
@ $0 |
|
| 12/17/2021 |
4
| Aradhye Shreeram (EVP & Chief Medical Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 833 shares
@ $38.05, valued at
$31.7k
Exercised 2,837 restricted stock units
@ $0 |
|
| 12/17/2021 |
4
| Weissman James B (COO & EVP) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 1,675 shares
@ $38.05, valued at
$63.7k
Exercised 3,775 restricted stock units
@ $0 |
|
| 12/17/2021 |
4
| FAMBROUGH DOUGLAS (CEO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 5,348 shares
@ $38.05, valued at
$203.5k
Exercised 13,750 restricted stock units
@ $0 |
|
| 12/17/2021 |
4
| Brown Bob D (Chief Scientific Ofr., EVP R&D) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 1,675 shares
@ $38.05, valued at
$63.7k
Exercised 3,775 restricted stock units
@ $0 |
|
| 12/17/2021 |
4
| Zeng Ling (Chief Legal Officer & Sec'y) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 752 shares
@ $38.05, valued at
$28.6k
Exercised 2,562 restricted stock units
@ $0 |
|
| 12/14/2021 |
4
| Ciappenelli Robert D. (Chief Strategy Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Exercised 8,856 options to buy
@ $22.58, valued at
$200k
|
|
| 12/13/2021 |
4
| FAMBROUGH DOUGLAS (CEO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Exercised 33,670 options to buy
@ $2.97, valued at
$100k
Exercised 146,195 options to buy
@ $3.42, valued at
$500k
|
|
| 11/22/2021 |
4
| Brown Bob D (Chief Scientific Ofr., EVP R&D) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 24,936 shares
@ $37.94, valued at
$946.1k
Exercised 24,936 options to buy
@ $3.42, valued at
$85.3k
|
|
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| Zeng Ling (Chief Legal Officer & Sec'y) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 1,334 shares
@ $21.47, valued at
$28.6k
Exercised 4,556 restricted stock units
@ $0 |
|
| 09/17/2021 |
4
| Aradhye Shreeram (EVP & Chief Medical Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 2,056 shares
@ $21.47, valued at
$44.1k
Exercised 7,025 restricted stock units
@ $0 |
|
| 08/10/2021 |
4
| FAMBROUGH DOUGLAS (President and CEO) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Bought 5,000 shares
@ $22.096, valued at
$110.5k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Brown Bob D (Chief Scientific Ofr., EVP R&D) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 8,312 shares
@ $37.377, valued at
$310.7k
Exercised 8,312 options to buy
@ $3.42, valued at
$28.4k
|
|
| 07/08/2021 |
4
| Paglia Regina M. (Chief Human Resources Officer) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 1,404 shares
@ $37.05, valued at
$52k
Exercised 1,450 restricted stock units
@ $0
Exercised 1,712 restricted stock units
@ $0 |
|
| 07/08/2021 |
4
| Weissman James B (COO & EVP) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 30,000 shares
@ $39.09, valued at
$1.2M
Exercised 30,000 options to buy
@ $9.09, valued at
$272.7k
|
|
| 07/06/2021 |
4
| Brown Bob D (Chief Scientific Ofr., EVP R&D) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 7,246 shares
@ $37.3029, valued at
$270.3k
Sold 1,066 shares
@ $37.8466, valued at
$40.3k
Exercised 8,312 options to buy
@ $3.42, valued at
$28.4k
|
|
|
|
|